0
Abstract: Poster Presentations |

A COMPARISON OF ENDOBRONCHIAL ULTRASOUND GUIDED BIOPSY AND POSITRON EMISSION TOMOGRAPHY WITH INTEGRATEDCOMPUTED TOMOGRAPHY IN LUNG CANCER STAGING FREE TO VIEW

Mark Krasnik, MD*; Felix Herth, MD; Peter Vilmann, MD; Birgit G. Skov, MD; Søren S. Larsen, MD
Author and Funding Information

Gentofte University Hospital, Copenhagen, Denmark


Chest


Chest. 2005;128(4_MeetingAbstracts):323S. doi:10.1378/chest.128.4_MeetingAbstracts.323S-b
Text Size: A A A
Published online

Abstract

PURPOSE:  Exact staging of patients with non-small-cell lung cancer (NSCLC) is important to improve selection of resectable and curable patients for surgery. Positron emission tomography with integrated computed tomography (PET/CT) and endoscopic ultrasound guided fine needle aspiration biopsy (EBUS-TBNA) are new and promising methods, but indications in lung cancer staging are controversial. No studies have compared the 2 methods. The aim of this study was to assess and compare the diagnostic values of PET/CT and EBUS-TBNA for diagnosing advanced lung cancer in patients, who had both procedures performed.

METHODS:  25 patients considered to be potential candidates for resection of verified or suspected NSCLC underwent PET/CT and EBUS-TBNA. The PET/CT and EBUS-TBNA diagnoses were confirmed either by open thoracotomy/scopy, mediastinoscopy or clinical follow-up. Mediastinal involment of lung cancer was defined as tumour-stage ≥ IIIA(N2), corresponding to N2-N3. Diagnostic values of PET/CT and EBUS-TBNA, with regard to the diagnosis of mediastinal involment of lung cancer, were assessed and compared.

RESULTS:  10 patients had a pos PETCT for mediastinal involment while mediastinal involment were found in 5 patients with EBUS TBNA.The sensitivity of PET/CT and EBUS-TBNA were respectively 67%% versus 100% for N2-N3 disease . PET/CT had a specificity of 68%, positive predictive value (PPV) of 40% and a negative predictive value (NPV) of 87%. EBUS-TBNA had a specificity of 100%, PPV of 100%, NPV of 100% for mediastinal involment.

CONCLUSION:  EBUS-TBNA had a sensitivity, NPV and PPV for diagnosing advanced lung cancer, superior to PET/CT.

DISCLOSURE:  Mark Krasnik, None.

Wednesday, November 2, 2005

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543